Retinoic acid‑incorporated glycol chitosan nanoparticles inhibit the expression of Ezh2 in U118 and U138 human glioma cells

Molecular Medicine Reports
Hu-Chen LuJi-Xin Shi

Abstract

At present, one of the most life threatening types of adult brain tumor is glioblastoma multiforme (GBM). The molecular mechanism underlying the progression of GBM remains to be fully elucidated. The modern method of clinical treatment has only improved the average survival rates of a newly diagnosed patients with GBM by ~15 months. Therefore, the discovery of novel molecules, which are involved in glioma inhibition is required. In the present study, U118 and U138 human glioma cells were transfected with all‑trans retinoic acid (RA)-incorporated glycol chitosan (GC) nanoparticles.An MTT assay was used for the analysis of cell proliferation and flow cytometric analysis and ssDNA detection assays were performed for the determination of induction of cell apoptosis. Cell cycle distribution was analyzed by flow cytometry. Exposure of the U118 and U138 human glioma cells to the RA‑incorporated GC nanoparticles for 24 h resulted in a concentration‑dependent inhibition of cell proliferation. Among the range of experimental RA concentrations, the minimum effective treatment concentration was 10 µM, with a half maximal inhibitory concentration of 25 µM. The results also demonstrated that RA transfection resulted in the inhibition of cell...Continue Reading

References

Jun 1, 1991·Archives of Biochemistry and Biophysics·E Z Szuts, F I Harosi
Jul 1, 1988·The Journal of Investigative Dermatology·P A LehmanT J Franz
May 29, 1995·International Journal of Cancer. Journal International Du Cancer·G KrupitzaC Dittrich
Jan 1, 1994·Progress in Growth Factor Research·P ten DijkeK Miyazono
Jan 17, 1997·International Journal of Cancer. Journal International Du Cancer·F GianniniM Boiocchi
Nov 3, 2004·Nature Reviews. Molecular Cell Biology·Stefan J Riedl, Yigong Shi
Feb 16, 2005·Journal of Controlled Release : Official Journal of the Controlled Release Society·Hyuk Sang YooSeo Young Jeong
Jul 21, 2005·Technology in Cancer Research & Treatment·K K Jain
Aug 4, 2006·Journal of Pharmaceutical Sciences·Young-Il JeongShin Jung
Aug 25, 2006·Molecular Cancer Therapeutics·Rajni SinhaDong M Shin
Nov 24, 2006·The Neurologist·Andrew D Norden, Patrick Y Wen
May 8, 2009·International Journal of Nanomedicine·Dhruba J BharaliShaker A Mousa
Sep 10, 2009·Current Opinion in Neurology·Walter Stummer, Marcel A Kamp
Nov 26, 2009·Cancer Research·Mario-Luca SuvàIvan Stamenkovic
Apr 21, 2010·Journal of Controlled Release : Official Journal of the Controlled Release Society·Kwangmeyung KimIck Chan Kwon
Jul 6, 2010·Nature Genetics·Thomas ErnstNicholas C P Cross
Oct 16, 2010·Neuropathology and Applied Neurobiology·F OrzanG Finocchiaro
Dec 24, 2010·Journal of Gastroenterology and Hepatology·Daisy P F Tsang, Alfred S L Cheng
Mar 4, 2011·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Andrew Chase, Nicholas C P Cross
May 18, 2011·FEBS Letters·Carolina Prezioso, Valerio Orlando
May 19, 2011·International Journal of Nanomedicine·Jun Jie WangShu Ling Wang
Jan 10, 2012·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Emanuele CrocettiUNKNOWN RARECARE working group
Nov 28, 2012·Nature Reviews. Clinical Oncology·Shota TanakaJorg Dietrich

❮ Previous
Next ❯

Methods Mentioned

BETA
PCR
transfection
flow cytometry

Software Mentioned

SPSS

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis